Immunotherapy clinical trials - a new approach to treating cancer

Vancouver, kelowna, and delta, british columbia--(newsfile corp. - september 19, 2024) - investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, featuring aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening viral infections. aethlon's hemopurifier® is a clinical stage immunotherapeutic device designed to combat cancer.
AEMD Ratings Summary
AEMD Quant Ranking